Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Highland Capital Management LLC

Highland Capital Management LLC trimmed its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 66.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,915 shares of the biotechnology company’s stock after selling 5,649 shares during the quarter. Highland Capital Management LLC’s holdings in Axon Enterprise were worth $1,732,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in AXON. Geode Capital Management LLC raised its position in Axon Enterprise by 2.0% in the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after acquiring an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP increased its holdings in Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after buying an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC lifted its position in shares of Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after acquiring an additional 83,265 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after acquiring an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment acquired a new stake in Axon Enterprise in the third quarter valued at $200,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Axon Enterprise

In related news, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $639.69, for a total value of $639,690.00. Following the sale, the director now directly owns 24,259 shares in the company, valued at $15,518,239.71. This trade represents a 3.96 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the transaction, the insider now directly owns 154,394 shares in the company, valued at approximately $91,691,508.72. The trade was a 12.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock valued at $30,721,337 in the last three months. Corporate insiders own 6.10% of the company’s stock.

Wall Street Analysts Forecast Growth

AXON has been the topic of a number of research reports. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. JMP Securities raised their price target on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Robert W. Baird boosted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Needham & Company LLC raised their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Finally, Northland Securities upped their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $524.85.

Axon Enterprise Stock Up 2.1 %

NASDAQ AXON opened at $653.43 on Friday. The business has a 50 day moving average price of $619.32 and a two-hundred day moving average price of $479.00. Axon Enterprise, Inc. has a fifty-two week low of $247.04 and a fifty-two week high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market cap of $49.82 billion, a PE ratio of 168.85, a P/E/G ratio of 6.41 and a beta of 1.04.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.